HIV policy indicators
| Indicator number | Name | Coding question |
| Clinical/treatment: policies related to HIV treatment and clinical services | ||
| CT1 | Treatment Initiation | Do national guidelines on when to initiate HIV treatment align with international recommendations? |
| CT2 | Same-day treatment start | Do national HIV treatment guidelines offer the possibility to start antiretrovial therapy (ART) the same day as HIV diagnosis? |
| CT3 | Treatment regimen | Does the first-line antiretrovial (ARV) regimen included in national HIV treatment guidelines align with international recommendations? |
| CT4 | Differentiated service delivery | Do national HIV guidelines incorporate differentiated service delivery for stable patients? |
| CT5 | Viral load testing | Do national guidelines on frequency of viral load monitoring align with international recommendations? |
| CT6 | Paediatric diagnosis and treatment | Do national guidelines for paediatric testing and treatment align with international recommendations? |
| CT7 | Migrant access to healthcare | Do national laws/policies allow all migrants access to HIV and primary healthcare services, regardless of their immigration status? |
| CT8 | TB diagnosis | Does national policy include use of rapid diagnostic tests (eg, rapid molecular tests, lateral flow urine lipoarabinomannan assay (LF-LAM)) as the initial diagnostic test for TB in “People Living With HIV/AIDS” (PLHIV)? |
| Testing/prevention: policies related to HIV testing, biomedical and sociobehavioural HIV prevention | ||
| TP1 | Self-testing | Does national law/policy allow for self-testing? |
| TP2 | Index testing w/ protections | Do national HIV guidelines incorporate index testing/partner notification, while prioritising robust protections for patient confidentiality? |
| TP3 | Compulsory testing | Does national law/policy prohibit compulsory HIV testing? |
| TP4 | Age restrictions on testing and treatment | Can adolescents access HIV testing and treatment without parental consent? |
| TP5 | PrEP | Does national policy make pre-exposure prophylaxis (PrEP) available to eligible populations in accordance with WHO guidelines? |
| TP6 | Harm reduction | Does national/law policy incorporate key harm reduction strategies? |
| TP7 | Comprehensive sexuality education | Does national policy require that comprehensive sexuality education be taught in primary and secondary schools? |
| TP8 | Prisoners prevention | Are both condoms/lubricants and needle/syringe programmes available to prisoners as a matter of policy? |
| Structural: policies related to structural-legal drivers of HIV | ||
| S1 | Same-sex criminalisation | Are consensual same-sex sexual acts decriminalised in law? |
| S2 | Sex work criminalisation | Is sex work decriminalised under national law? |
| S3 | Drug use criminalisation | Is personal drug possession/use decriminalised? |
| S4 | HIV exposure criminalisation | Does national law avoid criminalising and prosecuting people for HIV exposure/ transmission? |
| S5 | Non-discrimination protections | Do national/laws policies include protections from discrimination on the basis of sexual orientation, gender identity, and HIV status? |
| S6 | National human rights institutions | Is there an independent national human rights institution to which violations can be reported in compliance with the Paris principles? |
| S7 | Constitutional right to health | Is there an enforceable right to health in the national constitution? |
| S8 | Girls education | Is there a national policy in place to encourage secondary school retention among girls? |
| S9 | Gender-based violence | Does the law explicitly address domestic violence with enforceable penalties? |
| S10 | Civil society | Does national law/policy facilitate open participation by civil society in the AIDS response? |
| Health systems: policies related to financing and management of the health system | ||
| HS1 | Task shifting | Does national law/policy allow for nurses or other non-physicians to initiate HIV treatment? |
| HS2 | Health financing | Does national law/policy prioritise sustainable financing for the public health system? |
| HS3 | Universal health coverage (UHC) | Does the national universal health insurance scheme include medications for HIV treatment and PrEP? |
| HS4 | User fees | Are public healthcare services available without user fees at the point of service? |
| HS5 | Access to medicines | Does national law/policy take advantage of ‘TRIPS flexibilities’ for affordable medicines (ie, compulsory licensing/public non-commercial use, parallel import, and Least Developed Country transition provisions)? |
| HS6 | Unique identifiers w/ data protections | Does country have unique identifiers for continuity of care across multiple facilities while protecting patients' privacy? |
| HS7 | Data sharing | Is it country policy to publicly share disaggregated HIV data on a regular basis? |
TB, tuberculosis.